You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 10, October 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

How Effective and Safe Is Continuation Therapy in Elderly Depressed Patients?

Factors Affecting Relapse Rate

Anastasios Georgotas, MD; Robert E. McCue, MD; Thomas B. Cooper, MA; Narmada Nagachandran, MD; Irene Chang

Arch Gen Psychiatry. 1988;45(10):929-932.


Abstract

• Sixty elderly depressed patients who had responded to either nortriptyline hydrochloride or phenelzine sulfate were followed up under double-blind conditions during four to eight months of continuation treatment. Over 70% of patients (43) remained well during this period, while 11 (18.3%) had relapses, three (5.0%) dropped out because of side effects, and three (5.0%) prematurely terminated in good clinical condition. There was no significant difference in the relapse rate between patients receiving nortriptyline (five [16.7%]) and those receiving phenelzine (six [20.0%]). Patients receiving phenelzine were more likely to require dose reductions, and all three patients who dropped out because of side effects were receiving phenelzine. Patients with chronic depression (greater than two years' duration) accounted for all of the relapses.



Author Affiliations

From the Department of Psychiatry (Drs Georgotas and McCue) and the Depression Studies Program (Drs Georgotas, McCue, and Nagachandran and Ms Chang), New York University School of Medicine; Department of Clinical Psychopharmacology in Psychiatry, College of Physicians and Surgeons, Columbia University, New York (Mr Cooper); and Analytical Psychopharmacology Laboratory, Nathan Kline Institute and New York State Psychiatric Institute, New York (Mr Cooper).


Footnotes

Accepted for publication Jan 15, 1988.

Reprint requests to Department of Psychiatry, New York University Medical Center, 550 First Ave, New York, NY 10016 (Dr Georgotas).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of Relapse in Residual Depression by Cognitive Therapy: A Controlled Trial
Paykel et al.
Arch Gen Psychiatry 1999;56:829-835.
ABSTRACT | FULL TEXT  

Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression: A Randomized Controlled Trial in Patients Older Than 59 Years
Reynolds III et al.
JAMA 1999;281:39-45.
ABSTRACT | FULL TEXT  

Effectiveness of Treatments of Depression in Older Ambulatory Patients
McCusker et al.
Arch Intern Med 1998;158:705-712.
ABSTRACT | FULL TEXT  

Recovery in Geriatric Depression
Alexopoulos et al.
Arch Gen Psychiatry 1996;53:305-312.
ABSTRACT  

The Definition and Operational Criteria for Treatment Outcome of Major Depressive Disorder: A Review of the Current Research Literature
Prien et al.
Arch Gen Psychiatry 1991;48:796-800.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.